Status:
TERMINATED
Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in Brazil
Lead Sponsor:
GlaxoSmithKline
Conditions:
Influenza
Eligibility:
All Genders
65+ years
Brief Summary
The purpose of this research study is to estimate how many elderly people who have symptoms that look like influenza (i.e. an influenza-like illness) actually have the disease and how effective influe...
Eligibility Criteria
Inclusion
- Subjects who the investigator believes that they can and will comply with the requirements of the protocol.
- A male or female \>= 65 years of age.
- Written informed consent obtained from the subject.
- Presenting within the first 72 hours of an influenza-like illness. Influenza-like illness is defined as the presence of:
- Fever measured by the patient or physician and at least one of the following symptoms:
- Sore throat.
- Coryza (runny nose) and/or nasal congestion.
- Cough.
- Availability to be followed up by phone or in person after an interval of approximately 14 - 21 days.
Exclusion
- Receipt of any experimental influenza vaccine within 6 months of the onset of the influenza-like illness.
- Terminal stage of disease.
- Subjects living in a nursing home.
- Use of any investigational or non-registered product planned during the study period.
- Subjects who have already been enrolled in this study.
Key Trial Info
Start Date :
May 26 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 29 2009
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01171157
Start Date
May 26 2009
End Date
June 29 2009
Last Update
June 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Curitiba/Paraná, Paraná, Brazil, 80810-050